UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)

Gynecologic oncology, 2020-04, Vol.157 (1), p.161-166

2020

Volltextzugriff (PDF)

Predictive modeling of gene mutations for the survival outcomes of epithelial ovarian cancer patients

PloS one, 2024-07, Vol.19 (7), p.e0305273

2024

Volltextzugriff (PDF)

Dynamic Models of Environmental Data Envelopment Analysis with Stock and Flow Variables

Automation and remote control, 2020-07, Vol.81 (7), p.1330-1344

Ratner, S.V.

2020

Volltextzugriff (PDF)

Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers

Frontiers in oncology, 2018-08, Vol.8, p.303-303

2018

Volltextzugriff (PDF)

Dynamic Problems of Estimation of Ecological-Economic Efficiency of Regions Based on Basic Models of Data Envelopment Analysis

Automation and remote control, 2019-12, Vol.80 (12), p.2245-2258

Ratner, S. V.

2019

Volltextzugriff (PDF)

Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic Rearrangement

Clinical cancer research, 2018-07, Vol.24 (14), p.3282-3291

2018

Volltextzugriff (PDF)

Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer

PloS one, 2018-11, Vol.13 (11), p.e0207399-e0207399

2018

Volltextzugriff (PDF)

Gene expression of non-homologous end-joining pathways in the prognosis of ovarian cancer

iScience, 2023-10, Vol.26 (10), p.107934-107934, Article 107934

2023

Volltextzugriff (PDF)

Transforming Growth Factor Beta and Epithelial to Mesenchymal Transition Alter Homologous Recombination Repair Gene Expression and Sensitize BRCA Wild-Type Ovarian Cancer Cells to Olaparib

Cancers, 2023-08, Vol.15 (15), p.3919

2023

Volltextzugriff (PDF)

Triapine disrupts CtIP-mediated homologous recombination repair and sensitizes ovarian cancer cells to PARP and topoisomerase inhibitors

Molecular cancer research, 2014-03, Vol.12 (3), p.381-393

2014

Volltextzugriff (PDF)

Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes

Gynecologic and obstetric investigation, 2019-01, Vol.84 (3), p.290-297

2019

Volltextzugriff (PDF)

In silico screening identifies a novel small molecule inhibitor that counteracts PARP inhibitor resistance in ovarian cancer

Scientific reports, 2021-04, Vol.11 (1), p.8042-21, Article 8042

2021

Volltextzugriff (PDF)

Analysis of renewable energy projects’ implementation in Russia

Thermal engineering, 2017, Vol.64 (6), p.429-436

2017

Volltextzugriff (PDF)

Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective study

Gynecologic oncology, 2017-01, Vol.144 (1), p.77-82

2017

Volltextzugriff (PDF)

Financial toxicity in patients with gynecologic malignancies: a cross sectional study

Journal of Gynecologic Oncology, 2021, 32(6), , pp.1-10

2021

Volltextzugriff (PDF)

Analysis of the World Experience of Smart Grid Deployment: Economic Effectiveness Issues

Thermal engineering, 2018, Vol.65 (6), p.387-399

2018

Volltextzugriff (PDF)

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

Oncogene, 2012-10, Vol.31 (42), p.4559-4566

2012

Volltextzugriff (PDF)

Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study

Gynecologic oncology reports, 2020-11, Vol.34, p.100667-100667, Article 100667

2020

Volltextzugriff (PDF)

Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)

Gynecologic oncology reports, 2020-02, Vol.31, p.100532-100532, Article 100532

2020

Volltextzugriff (PDF)

When alcohol is the answer: Trapping, identifying and quantifying simple alkylating species in aqueous environments

Analytical biochemistry, 2016-09, Vol.508, p.34-37

2016

Volltextzugriff (PDF)

pH‐dependent general base catalyzed activation rather than isocyanate liberation may explain the superior anticancer efficacy of laromustine compared to related 1,2‐bis(methylsulfonyl)‐1‐(2‐chloroethyl)hydrazine prodrugs

Chemical biology & drug design, 2018-01, Vol.91 (1), p.62-74

2018

Volltextzugriff (PDF)

Corrigendum to “Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)” [Gynecol. Oncol. Rep. 31 (2020) 100532]

Gynecologic oncology reports, 2020-08, Vol.33, p.100590-100590, Article 100590

2020

Volltextzugriff (PDF)

A survey of gynecologic oncologists regarding the End-of-Life discussion: A pilot study

Gynecologic oncology, 2012-03, Vol.124 (3), p.471-473

2012

Volltextzugriff (PDF)

Reconstructive Conundrums in Dermatologic Surgery: The Nose

1, 2014

Volltextzugriff (PDF)

Constraints imposed by key-material resources on renewable energy development

Renewable & sustainable energy reviews, 2021-07, Vol.144, p.111011, Article 111011

2021

Volltextzugriff (PDF)

1 – 25 von 12.048

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(8.095)
Mit Volltextzugriff
(9.195)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(4.665)
Humans
(2.821)
Life Sciences & Biomedicine
(2.759)
Female
(1.281)
Physical Sciences
(1.256)
Male
(1.090)
Biological And Medical Sciences
(922)
Animals
(884)
Chemistry
(845)
Adult
(809)
Technology
(784)
Middle Aged
(733)
Physics
(718)
Medical Sciences
(701)
Social Sciences
(608)
Chemistry, Physical
(547)
Science & Technology - Other Topics
(526)
Adolescent
(427)
Materials Science
(426)
Aged
(425)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(3.775)
NUS Single-Journal Subscriptions
(3.302)
Free E-Journal (出版社公開部分のみ）
(3.115)
Ingenta
(3.042)
Journals@Ovid Full Text
(2.205)
Elsevier ScienceDirect Journals Complete
(1.495)
Nexis Uni (LexisNexis)
(1.480)
IngentaConnect Journals
(1.317)
EBSCOhost Business Source Ultimate
(1.133)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.092)
Wiley Online Library
(1.023)
JSTOR
(960)
Ebook Central Perpetual and DDA
(746)
Wiley Online Library
(680)
eBooks on EBSCOhost
(660)
Springer Journals
(421)
Nature Research
(356)
Taylor & Francis eBooks A-Z
(275)
Taylor & Francis
(273)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(270)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Library Journal
(671)
The American Banker
(460)
Plos One
(227)
Nature Biotechnology
(191)
The Journal Of Chemical Physics
(178)
Journal Of Taxation
(137)
Journal Of The American Chemical Society
(131)
Gynecologic Oncology
(100)
Transplantation
(94)
Diabetes Care
(79)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)

Predictive modeling of gene mutations for the survival outcomes of epithelial ovarian cancer patients

Dynamic Models of Environmental Data Envelopment Analysis with Stock and Flow Variables

Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers

Dynamic Problems of Estimation of Ecological-Economic Efficiency of Regions Based on Basic Models of Data Envelopment Analysis

Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic Rearrangement

Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer

Gene expression of non-homologous end-joining pathways in the prognosis of ovarian cancer

Transforming Growth Factor Beta and Epithelial to Mesenchymal Transition Alter Homologous Recombination Repair Gene Expression and Sensitize BRCA Wild-Type Ovarian Cancer Cells to Olaparib

Triapine disrupts CtIP-mediated homologous recombination repair and sensitizes ovarian cancer cells to PARP and topoisomerase inhibitors

Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes

In silico screening identifies a novel small molecule inhibitor that counteracts PARP inhibitor resistance in ovarian cancer

Analysis of renewable energy projects’ implementation in Russia

Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective study

Financial toxicity in patients with gynecologic malignancies: a cross sectional study

Analysis of the World Experience of Smart Grid Deployment: Economic Effectiveness Issues

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study

Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)

When alcohol is the answer: Trapping, identifying and quantifying simple alkylating species in aqueous environments

pH‐dependent general base catalyzed activation rather than isocyanate liberation may explain the superior anticancer efficacy of laromustine compared to related 1,2‐bis(methylsulfonyl)‐1‐(2‐chloroethyl)hydrazine prodrugs

Corrigendum to “Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)” [Gynecol. Oncol. Rep. 31 (2020) 100532]

A survey of gynecologic oncologists regarding the End-of-Life discussion: A pilot study

Reconstructive Conundrums in Dermatologic Surgery: The Nose

Constraints imposed by key-material resources on renewable energy development

Suchergebnisse filtern